P335: GENOMIC DETERMINANTS OF THERAPY RESPONSE IN ETV6-RUNX1 LEUKEMIA

• L. Oksa,
• S. Moisio,
• K. Maqbool,
• H. Foroughi,
• R. Kramer,
• A. Nikkilä,
• V. Zachariadis,
• M. Enge,
• K. Vepsäläinen,
• J. Duque-Afonso,
• J. Hauer,
• V. Wirta,
• O. Lohi,
• M. Heinäniemi

Affiliations

L. Oksa

1 Tampere Center for Child, Adolescent, and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere

S. Moisio

2 The Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland

K. Maqbool

3 Clinical Genomics facility, Science for Life Laboratory

H. Foroughi

3 Clinical Genomics facility, Science for Life Laboratory

R. Kramer

2 The Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland

A. Nikkilä

1 Tampere Center for Child, Adolescent, and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere

V. Zachariadis

5 Department of Oncology-Pathology, Karolinska Institute, Stockholm

M. Enge

5 Department of Oncology-Pathology, Karolinska Institute, Stockholm

K. Vepsäläinen

6 Department of Pediatrics, Kuopio University Hospital, Kuopio, Sweden

J. Duque-Afonso

7 Department of Hematology/Oncology/Stem Cell Transplantation, Faculty of Medicine, University of Freiburg Medical Center, Freiburg

J. Hauer

8 School of Medicine; Department of Pediatrics, Technical University of Munich, Munich, Germany

V. Wirta

3 Clinical Genomics facility, Science for Life Laboratory

O. Lohi

1 Tampere Center for Child, Adolescent, and Maternal Health Research, Faculty of Medicine and Health Technology, Tampere University, Tampere

M. Heinäniemi

2 The Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland